Cargando…
Fecal β-glucuronidase activity differs between hematopoietic cell and kidney transplantation and a possible mechanism for disparate dose requirements
The intestinal microbiota produces β-glucuronidase that plays an essential role in the metabolism of the immunosuppressant mycophenolate mofetil (MMF). This drug is commonly used in organ and hematopoietic cell transplantation (HCT), with variations in dosing across transplant types. We hypothesized...
Autores principales: | Khan, Mohammad Haneef, Onyeaghala, Guillaume C., Rashidi, Armin, Holtan, Shernan G., Khoruts, Alexander, Israni, Ajay, Jacobson, Pamala A., Staley, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351555/ https://www.ncbi.nlm.nih.gov/pubmed/35921529 http://dx.doi.org/10.1080/19490976.2022.2108279 |
Ejemplares similares
-
75200 Fecal Microbiota Transplantation to Prevent Infections in Patients with Acute Myeloid Leukemia: A Double-Blind Randomized Placebo-Controlled Phase 2 Clinical Trial
por: Ebadi, Armin Rashidiryam, et al.
Publicado: (2021) -
Gut microbiota response to antibiotics is personalized and depends on baseline microbiota
por: Rashidi, Armin, et al.
Publicado: (2021) -
Effect of COVID-19 precautions on the gut microbiota and nosocomial infections
por: Rashidi, Armin, et al.
Publicado: (2021) -
Loss of microbiota-derived protective metabolites after neutropenic fever
por: Rashidi, Armin, et al.
Publicado: (2022) -
Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia
por: Rashidi, Armin, et al.
Publicado: (2022)